Tag: Cayman Chemical

BLS Pharmaceuticals Expands International Psychedelic Medicines Network Through Cayman Chemical Partnership

by Psychedelics.Media Team

July 22, 2026

BLS Pharmaceuticals (ASX: BLS) has signed a referral agreement with US-based Cayman Chemical Company, expanding its international commercial network for ...

No Result

View All Result

Home
News
Business
Policy & Regulation
Research
Health & Therapy
Opinion
Contact

Not enough quota to unlock this post

Unlock left : 0

Tag: Cayman Chemical

BLS Pharmaceuticals Expands International Psychedelic Medicines Network Through Cayman Chemical Partnership

Newsletter

Stay Ahead of Psychedelic Medicine

Recommended

Bioxyne Strengthens Board with Appointment of Investor and Governance Executive Edward Myer

Psychiatry Is Starting to Treat Psychedelics as Medicine, Not a Movement

Popular Story

Incannex and the Next Test for Psychedelic Medicine

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

The Global Psychedelic Medicine Conference & Events Calendar 2026–2027

Eli Lilly Reportedly Nears Acquisition of AtaiBeckley in Potential Landmark Deal for Psychedelic Medicine

AbbVie’s $906M Psychedelic Bet: What It Means for Psychedelic Medicine

Recent Posts

Categories

Free Weekly Newsletter

Not enough quota to unlock this post

Are you sure want to cancel subscription?